ArticleBJR open2025
Combined with the semantic features of CT and selected clinical variables, a machine learning model for accurately predicting the prognosis of Omicron was established.
Article in BJR open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To efficiently use medical resources and offer optimal personalized treatment for individuals with Omicron infection, it is vital to predict the disease's outcome early on. This research developed three machine learning models to foresee the results for Omicron-infected patients. Methods: Data from 253 Omicron-infected patients, including their CT scans, clinical details, and relevant laboratory values, were studied. The patients were categorized into two groups based on their disease progression: favourable prognosis and unfavourable prognosis. Patients manifesting respiratory failure, acute liver or kidney impairment, or fatalities were placed in the "poor" group. Those lacking such symptoms were allocated to the "good" group. The participants were randomly split into training set (202) and validation set (51) with an 8:2 ratio. Radiomics features were produced using image processing, focused segmentation, feature extraction, and selection, leading to the establishment of a radiomics model. A univariate logistic regression method identified potential clinical factors contributing to a clinical model's development. Eventually, the fused feature set, integrating radiomics features and clinical indicators, was used for the combined model. The model's prediction performance was assessed using the area under the receiver operating characteristic curve (AUC). The model's clinical usefulness was evaluated by generating calibration and decision curves. Results: Compared to other classification models, the combined model showcased the best classification performance. It achieved an AUC of 0.848 and accuracy of 0.763 in the training set, and 0.797 and 0.750 in the validation set, respectively. Conclusions: This study employed machine learning model to accurately predict the prognosis of Omicron-infected patients. Advances in knowledge: (1) Topic innovation: At present, there is a lack of research on the use of CT images to construct machine learning models to predict the prognosis of patients with Omicron infection. This study intends to establish clinical, radiomics, and combined models to provide more possibilities for the identification of the two. (2) Platform innovation: The feature extraction and screening and the establishment of omics model in this study will be completed in the intelligent scientific research platform, which can reduce the error caused by human error, simplify the operation steps, and save the time of data processing time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.